House Dust Mite Respiratory Allergy : An Overview of Current Therapeutic Strategies
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved..
Although house dust mite (HDM) allergy is a major cause of respiratory allergic disease, specific diagnosis and effective treatment both present unresolved challenges. Guidelines for the treatment of allergic rhinitis and asthma are well supported in the literature, but specific evidence on the efficacy of pharmacotherapy treatment for known HDM-allergic patients is weaker. The standard diagnostic techniques--skin prick test and specific IgE testing--can be confounded by cross-reactivity. However, component-resolved diagnosis using purified and recombinant allergens can improve the accuracy of specific IgE testing, but availability is limited. Treatment options for HDM allergy are limited and include HDM avoidance, which is widely recommended as a strategy, although evidence for its efficacy is variable. Clinical efficacy of pharmacotherapy is well documented; however, symptom relief does not extend beyond the end of treatment. Finally, allergen immunotherapy has a poor but improving evidence base (notably on sublingual tablets) and its benefits last after treatment ends. This review identifies needs for deeper physician knowledge on the extent and impact of HDM allergy in respiratory disease, as well as further development and improved access to molecular allergy diagnosis. Furthermore, there is a need for the development of better-designed clinical trials to explore the utility of allergen-specific approaches, and uptake of data into guidance for physicians on more effective diagnosis and therapy of HDM respiratory allergy in practice.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
|---|---|
| Enthalten in: |
The journal of allergy and clinical immunology. In practice - 3(2015), 6 vom: 01. Nov., Seite 843-55 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Calderón, Moisés A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Allergen |
|---|
| Anmerkungen: |
Date Completed 31.08.2016 Date Revised 08.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jaip.2015.06.019 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM252488911 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM252488911 | ||
| 003 | DE-627 | ||
| 005 | 20231224164224.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaip.2015.06.019 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0841.xml |
| 035 | |a (DE-627)NLM252488911 | ||
| 035 | |a (NLM)26342746 | ||
| 035 | |a (PII)S2213-2198(15)00333-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Calderón, Moisés A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a House Dust Mite Respiratory Allergy |b An Overview of Current Therapeutic Strategies |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.08.2016 | ||
| 500 | |a Date Revised 08.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Although house dust mite (HDM) allergy is a major cause of respiratory allergic disease, specific diagnosis and effective treatment both present unresolved challenges. Guidelines for the treatment of allergic rhinitis and asthma are well supported in the literature, but specific evidence on the efficacy of pharmacotherapy treatment for known HDM-allergic patients is weaker. The standard diagnostic techniques--skin prick test and specific IgE testing--can be confounded by cross-reactivity. However, component-resolved diagnosis using purified and recombinant allergens can improve the accuracy of specific IgE testing, but availability is limited. Treatment options for HDM allergy are limited and include HDM avoidance, which is widely recommended as a strategy, although evidence for its efficacy is variable. Clinical efficacy of pharmacotherapy is well documented; however, symptom relief does not extend beyond the end of treatment. Finally, allergen immunotherapy has a poor but improving evidence base (notably on sublingual tablets) and its benefits last after treatment ends. This review identifies needs for deeper physician knowledge on the extent and impact of HDM allergy in respiratory disease, as well as further development and improved access to molecular allergy diagnosis. Furthermore, there is a need for the development of better-designed clinical trials to explore the utility of allergen-specific approaches, and uptake of data into guidance for physicians on more effective diagnosis and therapy of HDM respiratory allergy in practice | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Allergen | |
| 650 | 4 | |a Allergic asthma | |
| 650 | 4 | |a Allergic rhinitis | |
| 650 | 4 | |a Allergy | |
| 650 | 4 | |a House dust mite | |
| 650 | 4 | |a Respiratory allergic disease | |
| 650 | 4 | |a Specific diagnosis | |
| 650 | 4 | |a Treatment | |
| 650 | 7 | |a Allergens |2 NLM | |
| 700 | 1 | |a Kleine-Tebbe, Jörg |e verfasserin |4 aut | |
| 700 | 1 | |a Linneberg, Allan |e verfasserin |4 aut | |
| 700 | 1 | |a De Blay, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Hernandez Fernandez de Rojas, Dolores |e verfasserin |4 aut | |
| 700 | 1 | |a Virchow, Johann Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Demoly, Pascal |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of allergy and clinical immunology. In practice |d 2013 |g 3(2015), 6 vom: 01. Nov., Seite 843-55 |w (DE-627)NLM227247523 |x 2213-2201 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2015 |g number:6 |g day:01 |g month:11 |g pages:843-55 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaip.2015.06.019 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2015 |e 6 |b 01 |c 11 |h 843-55 | ||